Serco Group plc (the "Company") has been notified that, on 25 August 2010
Andrew Jenner, Finance Director, exercised 18,524 options, which had been
granted on 28 March 2001 under the Company's Executive Option Plan, at an
exercise price of 435 pence per share. The shares acquired on exercise were
sold on the London market at a price of 573.5 pence per share. On the same day
Mr Jenner and persons connected with him also sold 33,181 of the Company's
ordinary shares in the London market at 573.588 pence per share.
Mr Jenner has a beneficial interest in 289,574 ordinary shares in the Company,
with a value of 426% of his salary, and interests through the Company's
share-based incentive schemes in a further 1,231,221 shares in the Company.
This exceeds his requirement to hold shares valued at over 100% of salary.
In addition on the same day, Clive Barton, a person discharging managerial
responsibility, sold 87,300 of the Company's ordinary shares in the London
market at 573.588 pence per share.
This notice is given in fulfilment of obligations under DTR3.1.2R and DTR3.1.4R
(1)(a).
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.